Higher fasting blood glucose worsens knee symptoms in patients with radiographic knee osteoarthritis and comorbid central sensitization: an Iwaki cohort study
Authors:
Open Access
- 13 December 2022
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 24 (1) , 1-8
Abstract
Background: Although cross-sectional and cohort data suggest that higher serum blood glucose levels in patients with knee osteoarthritis (KOA) are associated with more severe knee symptoms, little is known about the longitudinal relationship between serum blood glucose and knee symptoms, particularly considering central sensitization (CS) comorbidity, which also worsens knee symptoms. Methods: We evaluated the longitudinal relationship between serum blood glucose and knee symptoms by dividing the cohort of patients with KOA into those with and without CS. We hypothesized that higher serum blood glucose levels would worsen knee symptoms. A total of 297 participants (mean age: 59.6 years; females: 211; average BMI: 23.7 kg/m2) were enrolled in this study. At baseline, plain radiographs of the bilateral knee joints were evaluated according to the Kellgren–Lawrence grade (KLG). All participants exhibited at least a KLG ≥ 2 in each knee. At baseline, fasting blood glucose (FBG) and Central Sensitization Inventory-9 (CSI-9) were evaluated; ≥ 10 points on the CSI-9 was defined as CS+. Knee injury and Osteoarthritis Outcome Score (KOOS) was evaluated at baseline and at 1-year follow-up; the change in KOOS (ΔKOOS) was calculated by subtracting the KOOS at baseline from that at the 1-year follow-up. Multiple linear regression analysis was conducted with ΔKOOS as the dependent variable and FBG at baseline as the independent variable, adjusted for age, sex, BMI, and CSI-9 at baseline. Results: Of the 297 subjects, 48 (16.2 %) were defined as CS+. In the CS − group, there was no association between FBG levels at baseline and ΔKOOS. In contrast, FBG at baseline was negatively associated with ΔKOOS pain (B = − 0.448; p = 0.003), ADL (B = − 0.438; p = 0.003), and sports (B = − 0.706; p = 0.007). Conclusions: In patients with radiographic KOA and CS, higher blood glucose levels were associated with deteriorated knee symptoms during the 1-year follow-up. Healthcare providers should pay attention to controlling blood glucose, particularly in patients with KOA and concurrent CS, to mitigate their knee symptoms. Study design: Retrospective cohort study (evidence level: III).Keywords
This publication has 33 references indexed in Scilit:
- The Development and Psychometric Validation of the Central Sensitization InventoryPain Practice, 2011
- Cross-cultural adaptation and validation of the Japanese Knee Injury and Osteoarthritis Outcome Score (KOOS)Journal of Orthopaedic Science, 2011
- Update on peripheral mechanisms of pain: beyond prostaglandins and cytokinesArthritis Research & Therapy, 2011
- IL-6- and NGF-Induced Rapid Control of Protein Synthesis and Nociceptive Plasticity via Convergent Signaling to the eIF4F ComplexJournal of Neuroscience, 2010
- Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2010
- The infrapatellar fat pad in knee osteoarthritis: An important source of interleukin‐6 and its soluble receptorArthritis & Rheumatism, 2009
- Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic painNeuropharmacology, 2009
- Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin‐6 in the rat: An inflammatory mechanism of joint painArthritis & Rheumatism, 2007
- Pathogenesis and management of pain in osteoarthritisThe Lancet, 2005
- Radiological Assessment of Osteo-ArthrosisAnnals of the Rheumatic Diseases, 1957